1Y Close · As of Aug 26, 2026
Englewood Lab operates in the Chemicals sector.
Legal name: Englewood Lab, Inc.
In fiscal year 2025, Englewood Lab (950140) reported revenue of 152 million KRW, up 14.1% from 134 million KRW a year earlier.
Operating profit was 26 million KRW and net income was 17 million KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 166.7 billion KRW, with a P/B of 1453.26.
These figures can be verified in the DART filing (receipt no. 20260316001080).
Recent Filings
Corporate Briefing (IR)
Semi-Annual Report (2026.06)
Consolidated Operating (Preliminary) Earnings (Fair Disclosure)
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-11 | Corporate Briefing (IR) |
| 2026-08-11 | Semi-Annual Report (2026.06) |
| 2026-08-10 | Consolidated Operating (Preliminary) Earnings (Fair Disclosure) |
| 2026-08-03 | Earnings Preview |